LAX 201Alternative Names: LAX-201
Latest Information Update: 23 Apr 2011
At a glance
- Originator Amarin Corporation
- Class Antidepressants
- Mechanism of Action Adrenergic receptor antagonists; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Depressive disorders
Most Recent Events
- 08 Nov 2006 Amarin Corporation is seeking partners to commercialise LAX 201 (http://www.amarincorp.com)